---
title: "Oasys LS-DYNA Environment Uses Tech Soft 3D's HOOPS Exchange to Expand CAD Import Support in Oasys PRIMER 23"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291445683.md"
description: "Oasys LS-DYNA Environment has integrated Tech Soft 3D's HOOPS Exchange SDK into Oasys PRIMER 23, expanding CAD import support from 3 to 16 formats. This enhancement allows engineering teams to directly import a broader range of native and neutral CAD models for Ansys LS-DYNA simulation pre-processing, improving workflow flexibility and efficiency."
datetime: "2026-07-01T16:39:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291445683.md)
  - [en](https://longbridge.com/en/news/291445683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291445683.md)
generator: "portal-rs"
---

# Oasys LS-DYNA Environment Uses Tech Soft 3D's HOOPS Exchange to Expand CAD Import Support in Oasys PRIMER 23

A partnership between Tech Soft 3D and Oasys LS-DYNA Environment resulted in the integration of Tech Soft 3D’s HOOPS Exchange into Oasys PRIMER 23 to enhance CAD import support from 3 to 16 formats. Tech Soft 3D, a key provider of engineering software development toolkits, focuses on CAD and CAE data conversion, visualization, and simulation tools. The collaboration aims to assist engineering teams in importing CAD geometry from various design systems while preparing models for simulation. This integration signifies a significant development in expanding the capabilities of Oasys PRIMER 23, offering more versatility and efficiency to users.

### Related Stocks

- [ANSS.US](https://longbridge.com/en/quote/ANSS.US.md)

## Related News & Research

- [Synopsys Inc Stock (SNPS) Closed Down by 5.63% on Sep 1: A Full Analysis](https://longbridge.com/en/news/297693476.md)
- [Synopsys Posts Q3 Beat On Strength In EDA, Growing Interest In Agentic AI](https://longbridge.com/en/news/297209549.md)
- [VMware defends ending downloads of SDK that helps VM backups– or migrations to rivals](https://longbridge.com/en/news/298526396.md)
- [WeChat Pay launches a smart-glasses SDK for QR-code payments](https://longbridge.com/en/news/298265160.md)
- [Kazia Therapeutics doses first patient in PNOC035 Phase 2 paxalisib-gemcitabine trial for recurrent pediatric AT/RT](https://longbridge.com/en/news/298449630.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**